Forte Biosciences, Inc. (FBRX)
Aug 27, 2026 - FBRX was delisted (reason: acquired by ARGX)
76.99
0.00 (0.00%)
Inactive · Last trade price on Aug 26, 2026
Forte Biosciences Employees
Forte Biosciences had 23 employees as of June 30, 2026. The number of employees increased by 6 or 35.29% compared to the same quarter last year.
Employees
23
Change
6
Growth
35.29%
Revenue / Employee
n/a
Profits / Employee
-$3,823,348
Market Cap
1.94B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 23 | 6 | 35.29% |
| Mar 31, 2026 | 22 | 8 | 57.14% |
| Dec 31, 2025 | 19 | 5 | 35.71% |
| Sep 30, 2025 | 16 | 5 | 45.45% |
| Jun 30, 2025 | 17 | 6 | 54.55% |
| Mar 31, 2025 | 14 | 3 | 27.27% |
| Dec 31, 2024 | 14 | 5 | 55.56% |
| Sep 30, 2024 | 11 | 2 | 22.22% |
| Jun 30, 2024 | 11 | 4 | 57.14% |
| Mar 31, 2024 | 11 | 4 | 57.14% |
| Dec 31, 2023 | 9 | 3 | 50.00% |
| Sep 30, 2023 | 9 | 3 | 50.00% |
| Jun 30, 2023 | 7 | 1 | 16.67% |
| Mar 31, 2023 | 7 | 2 | 40.00% |
| Dec 31, 2022 | 6 | 1 | 20.00% |
| Sep 30, 2022 | 6 | -4 | -40.00% |
| Jun 30, 2022 | 6 | -4 | -40.00% |
| Mar 31, 2022 | 5 | -4 | -44.44% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
FBRX News
- 21 days ago - Forte Biosciences Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Halper Sadeh LLC is Investigating Whether FBRX and SAFT are Obtaining Fair Deals for their Shareholders - GlobeNewsWire
- 5 weeks ago - Argenx to Buy Forte Biosciences for $2.2 Billion - WSJ
- 5 weeks ago - Argenx to buy Forte Biosciences for about $2.2 billion - Reuters
- 5 weeks ago - argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline - Business Wire
- 7 weeks ago - Forte Biosciences Transcript: Study result - Transcripts
- 7 weeks ago - Forte Biosciences Slides: Study result - Filings
- 7 weeks ago - Forte Biosciences Press release: Study result - Filings